Publicaciones en colaboración con investigadores/as de Hospital de Gran Canaria Dr. Negrin (77)

2022

  1. Association between the Prime Diet Quality Score and depressive symptoms in a Mediterranean population with metabolic syndrome. Cross-sectional and 2-year follow-up assessment from PREDIMED-PLUS study

    British Journal of Nutrition, Vol. 128, Núm. 6, pp. 1170-1179

  2. Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry (Rheumatology and Therapy, (2022), 9, 4, (1031-1047), 10.1007/s40744-022-00446-9)

    Rheumatology and Therapy

  3. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases*

    British Journal of Dermatology, Vol. 186, Núm. 1, pp. 142-152

  4. High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

    Journal of Infection, Vol. 85, Núm. 3, pp. 322-326

  5. Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry

    IJC Heart and Vasculature, Vol. 38

  6. Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections

    Scientific Reports, Vol. 12, Núm. 1

  7. Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients

    Clinical and Experimental Rheumatology

  8. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  9. Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry

    Rheumatology and Therapy, Vol. 9, Núm. 4, pp. 1031-1047

  10. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review

    Expert Opinion on Drug Safety, Vol. 21, Núm. 5, pp. 673-690